Today's Date: June 3, 2023
San Francisco Pride Announces Headliners Hayley Kiyoko and Princess Nokia for 53rd Annual SF Pride Parade & Celebration Feat   •   HESAI DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Hesai   •   UNice Celebrates LGBTQ Pride Month   •   SENTINELONE ALERT: Bragar Eagel & Squire, P.C. is Investigating SentinelOne, Inc. on Behalf of SentinelOne Stockholders and   •   Bijou Ikli named new CEO by Florida Assisted Living Association   •   INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of SentinelOne, Inc. (S) on Behalf of Investors   •   Statement from Minister Hutchings on progress in support of rural Canadians   •   Navidea Biopharmaceuticals, Inc. Receives NYSE American Notice   •   The Assembly of First Nations and the Government of Canada announce updates to school design standards for schools on-reserve   •   SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Funko, Inc. with Losses of $100,000 to Contact the Firm   •   56 Trilogy Health Services Communities Earn 2023 AHCA/NCAL Bronze National Quality Award   •   INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DZS Inc. (DZSI) on Behalf of Investors   •   Hilton brings back exclusive pop-up hotel experience 'Hilton on the Green' to the 2023 RBC Canadian Open   •   CURE HOSTS "AI FOR GOOD" SUPER SESSION TO MAKE SENSE OF BIG DATA AND HIGH TECH AT 2023 BIO INTERNATIONAL CONVENTION ON JUNE 5   •   ETHNIC CONFLICTS IN NIGERIA: UNMASKING THE PUPPET MASTERS   •   Rapid Dose Announces Proposed Private Placement Financing   •   Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of LivePerson, Inc. (LPSN) Investors   •   FNKO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Funko, Inc. Investors with Substantial Losses Have Opp   •   BURGERFI DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bu   •   Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y
Bookmark and Share

Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors

BURNABY, British Columbia , March 21 /Businesswire/ - Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all ages with type 1 and type 2 diabetes in Manitoba who meet eligibility criteria.

This press release features multimedia. View the full release here:

Manitobans of all ages with type 1 or type 2 diabetes on both basal and bolus insulin or using an insulin pump are now eligible for coverage of the Dexcom G6 CGM System through the Manitoba Pharmacare program. (Photo: Business Wire)

Manitobans of all ages with type 1 or type 2 diabetes on both basal and bolus insulin or using an insulin pump are now eligible for coverage of the Dexcom G6 CGM System through the Manitoba Pharmacare program. (Photo: Business Wire)

Expanding coverage for rtCGM to include all eligible patients with type 1 or type 2 diabetes establishes Manitoba as the leader among Canadian provinces. As of this announcement, Manitoba is currently the only province in Canada that does not require an application for preapproval of coverage which means improved access for patients and reduced workload for prescribers. The ease of access for rtCGM systems is now raising the bar for other jurisdictions across Canada to follow suit.

This positive step will ensure Manitobans are empowered to improve their self-management of diabetes at home, improving their patient experience, and preserving vital health system capacity by reducing the risk of severe hypoglycemia which often results in patients requiring emergency care.

“We praise Manitoba government’s leadership in expanding its coverage for Dexcom G6 to be inclusive of all individuals living with diabetes using insulin and simplifying the administrative burden and workload for prescribers. In today’s healthcare climate, reducing this burden is a huge step forward,” says André Côté, Vice President and General Manager, Dexcom Canada. “This decision is a true representation of what supporting the diabetes community looks like. I hope more provinces follow Manitoba’s lead.”

Dexcom rtCGM use is proven to improve glycemic control1,2 and can reduce the risk of costly long-term diabetes-related complications.3 Through Manitoba Pharmacare, people with type 1 or type 2 diabetes who meet the eligibility criteria can access Dexcom G6 as of March 14, 2023.

“I’m thrilled with Manitoba’s decision to broaden access to diabetes technology to people of all ages with type 1 or type 2 diabetes,” says Dr. Jennifer Yamamoto, Assistant Professor, Department of Internal Medicine, University of Manitoba. “More people in our province can now experience the benefits of real-time CGM for their diabetes management, which is an essential tool for increasing time spent in target glucose range, reducing occurrences of severe hypoglycemia and improving quality of life.”

Dexcom G6 uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a smart device* or receiver, giving patients real-time glucose data without the need to scan or prick their finger routinely. The system has customizable and predictive alerts and an urgent low alarm to help avoid potentially dangerous hypoglycemic events. The Dexcom G6 app also allows patients to share their glucose information with up to ten followers, enabling family, loved ones, and healthcare providers to remotely monitor patients for extra peace of mind.

Dexcom G6 also offers industry-leading connectivity through integrations with leading insulin delivery systems and digital health apps.

For more information about the coverage criteria for Manitoba Pharmacare, please visit

About Dexcom, Inc.

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California in the United States, and with operations in Canada, Dexcom has emerged as a leader in diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit

* For a list of compatible devices, please visit

† If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

‡ Following requires the use of the Follow app and an Internet connection. Followers should always confirm readings on the Dexcom G6 app before making diabetes treatment decisions.




Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA 2017;317(4):371-8.


Welsh JB, Gao P, Derdzinski M, et al. Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems. Diabetes Technol Ther 2019;21(3):128-32


Roze S, Isitt J, Smith-Palmer J, Lynch P. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor Versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada. Poster presentation presented at: 2020 Canadian Association for Population Therapeutics; October 27, 2020.


STORY TAGS: Photo/Multimedia, Biotechnology, Health, Diabetes, Medical Devices, Wearables/Mobile Technology, Technology, Apps/Applications, Mobile/Wireless, United States, North America, Canada, Product/Service, California, Manitoba,


White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News